AU6267796A

AU6267796A - Methods and devices for the removal of psoralens from blood products

Methods and devices for the removal of psoralens from blood products

Info

Publication number: AU6267796A
Authority: AU; Australia
Prior art keywords: blood; psoralen; resin; blood product; platelet
Prior art date: 1995-06-07
Legal status : Abandoned

Application number

AU62677/96A

Other languages

English (en)

Inventor

Derek J. Hei

Current Assignee

Cerus Corp

Original Assignee

Cerus Corp

Priority date

1995-06-07

Filing date

1996-06-07

Publication date

1996-12-30

1996-06-07 Application filed by Cerus Corp filed Critical Cerus Corp

1996-06-07 Priority claimed from US08/659,249 external-priority patent/US6544727B1/en

1996-12-30 Publication of AU6267796A publication Critical patent/AU6267796A/en

2000-08-02 Priority to AU48991/00A priority Critical patent/AU757224B2/en

Status Abandoned legal-status Critical Current

Links

238000000034 method Methods 0.000 title claims abstract description 248
239000010836 blood and blood product Substances 0.000 title claims abstract description 208
229940125691 blood product Drugs 0.000 title claims abstract description 207
ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical compound C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 claims abstract description 445
VXGRJERITKFWPL-UHFFFAOYSA-N 4',5'-Dihydropsoralen Natural products C1=C2OC(=O)C=CC2=CC2=C1OCC2 VXGRJERITKFWPL-UHFFFAOYSA-N 0.000 claims abstract description 211
229920005989 resin Polymers 0.000 claims abstract description 170
239000011347 resin Substances 0.000 claims abstract description 170
238000002617 apheresis Methods 0.000 claims abstract description 60
239000003463 adsorbent Substances 0.000 claims description 233
210000004369 blood Anatomy 0.000 claims description 146
239000008280 blood Substances 0.000 claims description 146
244000052769 pathogen Species 0.000 claims description 89
239000000203 mixture Substances 0.000 claims description 87
230000002186 photoactivation Effects 0.000 claims description 69
150000007523 nucleic acids Chemical class 0.000 claims description 66
108020004707 nucleic acids Proteins 0.000 claims description 65
102000039446 nucleic acids Human genes 0.000 claims description 65
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 37
239000004793 Polystyrene Substances 0.000 claims description 37
229920002223 polystyrene Polymers 0.000 claims description 37
229920000642 polymer Polymers 0.000 claims description 33
-1 diethylaminopropyloxy Chemical group 0.000 claims description 28
238000000926 separation method Methods 0.000 claims description 26
238000005192 partition Methods 0.000 claims description 25
230000000415 inactivating effect Effects 0.000 claims description 22
238000005202 decontamination Methods 0.000 claims description 20
238000001727 in vivo Methods 0.000 claims description 20
150000001412 amines Chemical group 0.000 claims description 18
230000003588 decontaminative effect Effects 0.000 claims description 17
FMHHVULEAZTJMA-UHFFFAOYSA-N 4,5',8-Trimethyl psoralen Natural products CC1=CC(=O)OC2=C1C=C1C=C(C)OC1=C2C FMHHVULEAZTJMA-UHFFFAOYSA-N 0.000 claims description 15
238000004891 communication Methods 0.000 claims description 7
150000002148 esters Chemical class 0.000 claims description 7
229910019142 PO4 Inorganic materials 0.000 claims description 5
LQDFTMLCQBZFKE-UHFFFAOYSA-N 4-bromo-9-methoxyfuro[3,2-g]chromen-7-one Chemical compound C1=CC(=O)OC2=C1C(Br)=C1C=COC1=C2OC LQDFTMLCQBZFKE-UHFFFAOYSA-N 0.000 claims description 4
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 4
239000010452 phosphate Substances 0.000 claims description 4
239000003634 thrombocyte concentrate Substances 0.000 abstract description 100
230000000694 effects Effects 0.000 abstract description 59
230000008569 process Effects 0.000 abstract description 41
230000002411 adverse Effects 0.000 abstract description 17
102000015081 Blood Coagulation Factors Human genes 0.000 abstract description 9
108010039209 Blood Coagulation Factors Proteins 0.000 abstract description 9
239000003114 blood coagulation factor Substances 0.000 abstract description 9
210000001772 blood platelet Anatomy 0.000 description 381
150000001875 compounds Chemical class 0.000 description 293
210000002381 plasma Anatomy 0.000 description 124
238000001179 sorption measurement Methods 0.000 description 113
239000000243 solution Substances 0.000 description 110
229920001429 chelating resin Polymers 0.000 description 94
230000002779 inactivation Effects 0.000 description 86
238000003860 storage Methods 0.000 description 71
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 70
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 68
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 68
230000006870 function Effects 0.000 description 67
230000015572 biosynthetic process Effects 0.000 description 62
210000004027 cell Anatomy 0.000 description 60
229910001868 water Inorganic materials 0.000 description 57
238000003786 synthesis reaction Methods 0.000 description 55
239000000306 component Substances 0.000 description 50
238000011282 treatment Methods 0.000 description 49
239000000047 product Substances 0.000 description 48
238000002474 experimental method Methods 0.000 description 47
238000012360 testing method Methods 0.000 description 46
239000000523 sample Substances 0.000 description 44
239000000463 material Substances 0.000 description 43
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 42
238000006243 chemical reaction Methods 0.000 description 41
125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 41
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 36
239000000126 substance Substances 0.000 description 35
238000003556 assay Methods 0.000 description 34
239000007787 solid Substances 0.000 description 34
238000002360 preparation method Methods 0.000 description 33
230000001717 pathogenic effect Effects 0.000 description 32
238000005286 illumination Methods 0.000 description 31
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 30
241000725303 Human immunodeficiency virus Species 0.000 description 30
231100000299 mutagenicity Toxicity 0.000 description 30
230000007886 mutagenicity Effects 0.000 description 30
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 29
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 29
238000005481 NMR spectroscopy Methods 0.000 description 29
229960000850 trioxysalen Drugs 0.000 description 27
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 26
241000894006 Bacteria Species 0.000 description 25
230000005670 electromagnetic radiation Effects 0.000 description 25
239000010410 layer Substances 0.000 description 25
239000002904 solvent Substances 0.000 description 25
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 24
241000700605 Viruses Species 0.000 description 24
239000012530 fluid Substances 0.000 description 24
229920001467 poly(styrenesulfonates) Polymers 0.000 description 24
239000011148 porous material Substances 0.000 description 24
IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 23
229910000041 hydrogen chloride Inorganic materials 0.000 description 23
239000002245 particle Substances 0.000 description 23
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 22
HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 22
230000005855 radiation Effects 0.000 description 22
238000004128 high performance liquid chromatography Methods 0.000 description 20
238000003752 polymerase chain reaction Methods 0.000 description 20
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 19
235000019441 ethanol Nutrition 0.000 description 19
238000004519 manufacturing process Methods 0.000 description 19
MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 18
238000011534 incubation Methods 0.000 description 18
238000009736 wetting Methods 0.000 description 18
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 17
239000007864 aqueous solution Substances 0.000 description 17
239000000725 suspension Substances 0.000 description 17
WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 16
239000002585 base Substances 0.000 description 16
230000003505 mutagenic effect Effects 0.000 description 16
229910052760 oxygen Inorganic materials 0.000 description 16
108020004414 DNA Proteins 0.000 description 15
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 15
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 15
239000003814 drug Substances 0.000 description 15
239000008103 glucose Substances 0.000 description 15
SQBBOVROCFXYBN-UHFFFAOYSA-N methoxypsoralen Natural products C1=C2OC(=O)C(OC)=CC2=CC2=C1OC=C2 SQBBOVROCFXYBN-UHFFFAOYSA-N 0.000 description 15
229920000728 polyester Polymers 0.000 description 15
238000012545 processing Methods 0.000 description 15
TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 14
239000007832 Na2SO4 Substances 0.000 description 14
PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 14
230000002776 aggregation Effects 0.000 description 14
238000004220 aggregation Methods 0.000 description 14
229940125782 compound 2 Drugs 0.000 description 14
230000007246 mechanism Effects 0.000 description 14
230000010076 replication Effects 0.000 description 14
239000011780 sodium chloride Substances 0.000 description 14
229910052938 sodium sulfate Inorganic materials 0.000 description 14
102100023472 P-selectin Human genes 0.000 description 13
238000010790 dilution Methods 0.000 description 13
239000012895 dilution Substances 0.000 description 13
229940079593 drug Drugs 0.000 description 13
229920003023 plastic Polymers 0.000 description 13
239000004033 plastic Substances 0.000 description 13
150000003839 salts Chemical class 0.000 description 13
108091003079 Bovine Serum Albumin Proteins 0.000 description 12
LNUFLCYMSVYYNW-ZPJMAFJPSA-N [(2r,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[[(3s,5s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-4,5-disulfo Chemical compound O([C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1C[C@@H]2CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CCCC(C)C)[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]1OS(O)(=O)=O LNUFLCYMSVYYNW-ZPJMAFJPSA-N 0.000 description 12
238000013459 approach Methods 0.000 description 12
238000009472 formulation Methods 0.000 description 12
230000001951 hemoperfusion Effects 0.000 description 12
239000002609 medium Substances 0.000 description 12
241000894007 species Species 0.000 description 12
125000001424 substituent group Chemical group 0.000 description 12
238000006467 substitution reaction Methods 0.000 description 12
HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 11
239000004677 Nylon Substances 0.000 description 11
239000002253 acid Substances 0.000 description 11
239000003146 anticoagulant agent Substances 0.000 description 11
229940127219 anticoagulant drug Drugs 0.000 description 11
230000001580 bacterial effect Effects 0.000 description 11
229910052799 carbon Inorganic materials 0.000 description 11
230000003247 decreasing effect Effects 0.000 description 11
238000013461 design Methods 0.000 description 11
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 11
230000003993 interaction Effects 0.000 description 11
229920002521 macromolecule Polymers 0.000 description 11
238000005259 measurement Methods 0.000 description 11
230000035772 mutation Effects 0.000 description 11
229920001778 nylon Polymers 0.000 description 11
239000013615 primer Substances 0.000 description 11
230000009467 reduction Effects 0.000 description 11
238000006722 reduction reaction Methods 0.000 description 11
230000004044 response Effects 0.000 description 11
231100000039 Ames test Toxicity 0.000 description 10
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 10
YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical group C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 10
239000006137 Luria-Bertani broth Substances 0.000 description 10
108010035766 P-Selectin Proteins 0.000 description 10
230000005540 biological transmission Effects 0.000 description 10
239000012503 blood component Substances 0.000 description 10
239000003610 charcoal Substances 0.000 description 10
239000003795 chemical substances by application Substances 0.000 description 10
ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 10
210000003743 erythrocyte Anatomy 0.000 description 10
239000012091 fetal bovine serum Substances 0.000 description 10
239000010419 fine particle Substances 0.000 description 10
230000012010 growth Effects 0.000 description 10
238000000338 in vitro Methods 0.000 description 10
230000002829 reductive effect Effects 0.000 description 10
238000001228 spectrum Methods 0.000 description 10
208000010110 spontaneous platelet aggregation Diseases 0.000 description 10
AOSZTAHDEDLTLQ-AZKQZHLXSA-N (1S,2S,4R,8S,9S,11S,12R,13S,19S)-6-[(3-chlorophenyl)methyl]-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one Chemical compound C([C@@H]1C[C@H]2[C@H]3[C@]([C@]4(C=CC(=O)C=C4[C@@H](F)C3)C)(F)[C@@H](O)C[C@@]2([C@@]1(C1)C(=O)CO)C)N1CC1=CC=CC(Cl)=C1 AOSZTAHDEDLTLQ-AZKQZHLXSA-N 0.000 description 9
238000005160 1H NMR spectroscopy Methods 0.000 description 9
229920001817 Agar Polymers 0.000 description 9
229940126657 Compound 17 Drugs 0.000 description 9
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
239000008272 agar Substances 0.000 description 9
238000005119 centrifugation Methods 0.000 description 9
229940125904 compound 1 Drugs 0.000 description 9
238000010586 diagram Methods 0.000 description 9
MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 9
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 9
238000001914 filtration Methods 0.000 description 9
238000005755 formation reaction Methods 0.000 description 9
229910052739 hydrogen Inorganic materials 0.000 description 9
231100000219 mutagenic Toxicity 0.000 description 9
230000037361 pathway Effects 0.000 description 9
239000002953 phosphate buffered saline Substances 0.000 description 9
229920002338 polyhydroxyethylmethacrylate Polymers 0.000 description 9
238000011160 research Methods 0.000 description 9
210000001995 reticulocyte Anatomy 0.000 description 9
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 8
JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 8
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 8
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 8
230000004913 activation Effects 0.000 description 8
238000004458 analytical method Methods 0.000 description 8
239000011324 bead Substances 0.000 description 8
230000006378 damage Effects 0.000 description 8
150000004985 diamines Chemical class 0.000 description 8
201000010099 disease Diseases 0.000 description 8
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
239000012458 free base Substances 0.000 description 8
239000000543 intermediate Substances 0.000 description 8
239000012633 leachable Substances 0.000 description 8
239000003471 mutagenic agent Substances 0.000 description 8
231100000707 mutagenic chemical Toxicity 0.000 description 8
239000012071 phase Substances 0.000 description 8
239000001103 potassium chloride Substances 0.000 description 8
235000011164 potassium chloride Nutrition 0.000 description 8
102000004169 proteins and genes Human genes 0.000 description 8
108090000623 proteins and genes Proteins 0.000 description 8
150000003384 small molecules Chemical class 0.000 description 8
230000001954 sterilising effect Effects 0.000 description 8
238000004659 sterilization and disinfection Methods 0.000 description 8
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 7
241000725618 Duck hepatitis B virus Species 0.000 description 7
BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 7
PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 7
230000008859 change Effects 0.000 description 7
230000007423 decrease Effects 0.000 description 7
238000001514 detection method Methods 0.000 description 7
238000011049 filling Methods 0.000 description 7
210000000265 leukocyte Anatomy 0.000 description 7
229910001629 magnesium chloride Inorganic materials 0.000 description 7
238000012423 maintenance Methods 0.000 description 7
239000012528 membrane Substances 0.000 description 7
238000002156 mixing Methods 0.000 description 7
PHEDXBVPIONUQT-RGYGYFBISA-N phorbol 13-acetate 12-myristate Chemical compound C([C@]1(O)C(=O)C(C)=C[C@H]1[C@@]1(O)[C@H](C)[C@H]2OC(=O)CCCCCCCCCCCCC)C(CO)=C[C@H]1[C@H]1[C@]2(OC(C)=O)C1(C)C PHEDXBVPIONUQT-RGYGYFBISA-N 0.000 description 7
210000004623 platelet-rich plasma Anatomy 0.000 description 7
239000013641 positive control Substances 0.000 description 7
238000011533 pre-incubation Methods 0.000 description 7
239000011541 reaction mixture Substances 0.000 description 7
239000000377 silicon dioxide Substances 0.000 description 7
238000000638 solvent extraction Methods 0.000 description 7
238000003756 stirring Methods 0.000 description 7
238000012546 transfer Methods 0.000 description 7
241001515965 unidentified phage Species 0.000 description 7
230000003612 virological effect Effects 0.000 description 7
108091093088 Amplicon Proteins 0.000 description 6
239000007995 HEPES buffer Substances 0.000 description 6
PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 6
125000000217 alkyl group Chemical group 0.000 description 6
125000003277 amino group Chemical group 0.000 description 6
230000003321 amplification Effects 0.000 description 6
230000036770 blood supply Effects 0.000 description 6
239000000872 buffer Substances 0.000 description 6
150000001721 carbon Chemical group 0.000 description 6
125000004432 carbon atom Chemical group C* 0.000 description 6
230000035602 clotting Effects 0.000 description 6
238000011109 contamination Methods 0.000 description 6
229960000956 coumarin Drugs 0.000 description 6
235000001671 coumarin Nutrition 0.000 description 6
238000000502 dialysis Methods 0.000 description 6
239000007789 gas Substances 0.000 description 6
230000001738 genotoxic effect Effects 0.000 description 6
230000005283 ground state Effects 0.000 description 6
230000002209 hydrophobic effect Effects 0.000 description 6
230000014759 maintenance of location Effects 0.000 description 6
238000003199 nucleic acid amplification method Methods 0.000 description 6
239000003960 organic solvent Substances 0.000 description 6
239000001301 oxygen Substances 0.000 description 6
239000013612 plasmid Substances 0.000 description 6
BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 6
KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 description 6
230000000717 retained effect Effects 0.000 description 6
239000002002 slurry Substances 0.000 description 6
VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 6
RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 6
238000001291 vacuum drying Methods 0.000 description 6
108091032973 (ribonucleotides)n+m Proteins 0.000 description 5
SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 5
238000010953 Ames test Methods 0.000 description 5
108010089414 Anaphylatoxins Proteins 0.000 description 5
206010051779 Bone marrow toxicity Diseases 0.000 description 5
MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 5
241000713772 Human immunodeficiency virus 1 Species 0.000 description 5
QXKHYNVANLEOEG-UHFFFAOYSA-N Methoxsalen Chemical compound C1=CC(=O)OC2=C1C=C1C=COC1=C2OC QXKHYNVANLEOEG-UHFFFAOYSA-N 0.000 description 5
PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 5
229930040373 Paraformaldehyde Natural products 0.000 description 5
239000012911 assay medium Substances 0.000 description 5
230000000712 assembly Effects 0.000 description 5
238000000429 assembly Methods 0.000 description 5
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
231100000366 bone marrow toxicity Toxicity 0.000 description 5
239000012267 brine Substances 0.000 description 5
239000003153 chemical reaction reagent Substances 0.000 description 5
230000000295 complement effect Effects 0.000 description 5
229920001577 copolymer Polymers 0.000 description 5
239000012043 crude product Substances 0.000 description 5
229910001882 dioxygen Inorganic materials 0.000 description 5
239000002158 endotoxin Substances 0.000 description 5
239000000284 extract Substances 0.000 description 5
239000012632 extractable Substances 0.000 description 5
230000037433 frameshift Effects 0.000 description 5
239000011521 glass Substances 0.000 description 5
150000002430 hydrocarbons Chemical group 0.000 description 5
230000000670 limiting effect Effects 0.000 description 5
238000010943 off-gassing Methods 0.000 description 5
229920002866 paraformaldehyde Polymers 0.000 description 5
238000007789 sealing Methods 0.000 description 5
230000035945 sensitivity Effects 0.000 description 5
210000002966 serum Anatomy 0.000 description 5
229910000162 sodium phosphate Inorganic materials 0.000 description 5
HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 5
230000032258 transport Effects 0.000 description 5
IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 4
SZFDQMKAGLCYPA-UHFFFAOYSA-N 1-phenylbutylbenzene Chemical compound C=1C=CC=CC=1C(CCC)C1=CC=CC=C1 SZFDQMKAGLCYPA-UHFFFAOYSA-N 0.000 description 4
IJRKANNOPXMZSG-SSPAHAAFSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC(=O)CC(O)(C(O)=O)CC(O)=O IJRKANNOPXMZSG-SSPAHAAFSA-N 0.000 description 4
229920000936 Agarose Polymers 0.000 description 4
102000004506 Blood Proteins Human genes 0.000 description 4
108010017384 Blood Proteins Proteins 0.000 description 4
XJUZRXYOEPSWMB-UHFFFAOYSA-N Chloromethyl methyl ether Chemical compound COCCl XJUZRXYOEPSWMB-UHFFFAOYSA-N 0.000 description 4
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 4
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 4
101000622137 Homo sapiens P-selectin Proteins 0.000 description 4
229930195725 Mannitol Natural products 0.000 description 4
108010071390 Serum Albumin Proteins 0.000 description 4
102000007562 Serum Albumin Human genes 0.000 description 4
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 4
206010070863 Toxicity to various agents Diseases 0.000 description 4
238000010521 absorption reaction Methods 0.000 description 4
230000003213 activating effect Effects 0.000 description 4
239000000654 additive Substances 0.000 description 4
150000001540 azides Chemical class 0.000 description 4
230000004888 barrier function Effects 0.000 description 4
230000037429 base substitution Effects 0.000 description 4
230000008901 benefit Effects 0.000 description 4
230000001588 bifunctional effect Effects 0.000 description 4
229960002685 biotin Drugs 0.000 description 4
235000020958 biotin Nutrition 0.000 description 4
239000011616 biotin Substances 0.000 description 4
210000000601 blood cell Anatomy 0.000 description 4
238000004140 cleaning Methods 0.000 description 4
238000000576 coating method Methods 0.000 description 4
229940126214 compound 3 Drugs 0.000 description 4
239000012141 concentrate Substances 0.000 description 4
235000008504 concentrate Nutrition 0.000 description 4
238000004132 cross linking Methods 0.000 description 4
239000003431 cross linking reagent Substances 0.000 description 4
NKDDWNXOKDWJAK-UHFFFAOYSA-N dimethoxymethane Chemical compound COCOC NKDDWNXOKDWJAK-UHFFFAOYSA-N 0.000 description 4
239000012153 distilled water Substances 0.000 description 4
239000004023 fresh frozen plasma Substances 0.000 description 4
231100000025 genetic toxicology Toxicity 0.000 description 4
230000036541 health Effects 0.000 description 4
229960002897 heparin Drugs 0.000 description 4
229920000669 heparin Polymers 0.000 description 4
208000015181 infectious disease Diseases 0.000 description 4
238000001802 infusion Methods 0.000 description 4
238000002347 injection Methods 0.000 description 4
239000007924 injection Substances 0.000 description 4
239000000594 mannitol Substances 0.000 description 4
235000010355 mannitol Nutrition 0.000 description 4
230000002503 metabolic effect Effects 0.000 description 4
229960004469 methoxsalen Drugs 0.000 description 4
238000003032 molecular docking Methods 0.000 description 4
239000000178 monomer Substances 0.000 description 4
230000007935 neutral effect Effects 0.000 description 4
235000021317 phosphate Nutrition 0.000 description 4
XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 4
230000037452 priming Effects 0.000 description 4
229920013730 reactive polymer Polymers 0.000 description 4
238000010992 reflux Methods 0.000 description 4
239000000741 silica gel Substances 0.000 description 4
229910002027 silica gel Inorganic materials 0.000 description 4
239000001632 sodium acetate Substances 0.000 description 4
235000017281 sodium acetate Nutrition 0.000 description 4
239000001509 sodium citrate Substances 0.000 description 4
NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 4
239000001488 sodium phosphate Substances 0.000 description 4
239000002594 sorbent Substances 0.000 description 4
PFNFFQXMRSDOHW-UHFFFAOYSA-N spermine Chemical compound NCCCNCCCCNCCCN PFNFFQXMRSDOHW-UHFFFAOYSA-N 0.000 description 4
230000002269 spontaneous effect Effects 0.000 description 4
UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
239000006228 supernatant Substances 0.000 description 4
125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 4
238000004809 thin layer chromatography Methods 0.000 description 4
239000003053 toxin Substances 0.000 description 4
231100000765 toxin Toxicity 0.000 description 4
108700012359 toxins Proteins 0.000 description 4
RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 4
238000003466 welding Methods 0.000 description 4
208000030507 AIDS Diseases 0.000 description 3
ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 3
ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 3
UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
206010053567 Coagulopathies Diseases 0.000 description 3
102000008186 Collagen Human genes 0.000 description 3
108010035532 Collagen Proteins 0.000 description 3
AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 3
241000699666 Mus <mouse, genus> Species 0.000 description 3
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
238000012408 PCR amplification Methods 0.000 description 3
239000005700 Putrescine Substances 0.000 description 3
150000007513 acids Chemical class 0.000 description 3
238000000137 annealing Methods 0.000 description 3
125000003118 aryl group Chemical group 0.000 description 3
239000012298 atmosphere Substances 0.000 description 3
230000004071 biological effect Effects 0.000 description 3
238000004364 calculation method Methods 0.000 description 3
230000000711 cancerogenic effect Effects 0.000 description 3
229920001436 collagen Polymers 0.000 description 3
239000000470 constituent Substances 0.000 description 3
239000000356 contaminant Substances 0.000 description 3
238000001816 cooling Methods 0.000 description 3
239000013078 crystal Substances 0.000 description 3
RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 3
239000003599 detergent Substances 0.000 description 3
238000009792 diffusion process Methods 0.000 description 3
238000009826 distribution Methods 0.000 description 3
238000001035 drying Methods 0.000 description 3
238000005516 engineering process Methods 0.000 description 3
239000000835 fiber Substances 0.000 description 3
238000005187 foaming Methods 0.000 description 3
230000005484 gravity Effects 0.000 description 3
238000010438 heat treatment Methods 0.000 description 3
150000003840 hydrochlorides Chemical class 0.000 description 3
239000001257 hydrogen Chemical group 0.000 description 3
125000004435 hydrogen atom Chemical group [H]* 0.000 description 3
125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
238000000099 in vitro assay Methods 0.000 description 3
238000010348 incorporation Methods 0.000 description 3
238000001990 intravenous administration Methods 0.000 description 3
230000001678 irradiating effect Effects 0.000 description 3
150000002632 lipids Chemical class 0.000 description 3
229940040511 liver extract Drugs 0.000 description 3
238000002844 melting Methods 0.000 description 3
230000008018 melting Effects 0.000 description 3
230000004048 modification Effects 0.000 description 3
238000012986 modification Methods 0.000 description 3
239000012452 mother liquor Substances 0.000 description 3
IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 3
238000002414 normal-phase solid-phase extraction Methods 0.000 description 3
239000006916 nutrient agar Substances 0.000 description 3
230000003287 optical effect Effects 0.000 description 3
230000036961 partial effect Effects 0.000 description 3
238000006552 photochemical reaction Methods 0.000 description 3
108091033319 polynucleotide Proteins 0.000 description 3
102000040430 polynucleotide Human genes 0.000 description 3
239000002157 polynucleotide Substances 0.000 description 3
229920003053 polystyrene-divinylbenzene Polymers 0.000 description 3
229910000027 potassium carbonate Inorganic materials 0.000 description 3
239000002244 precipitate Substances 0.000 description 3
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
238000011084 recovery Methods 0.000 description 3
230000035939 shock Effects 0.000 description 3
238000007086 side reaction Methods 0.000 description 3
239000011734 sodium Substances 0.000 description 3
FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
239000007858 starting material Substances 0.000 description 3
239000011550 stock solution Substances 0.000 description 3
230000004083 survival effect Effects 0.000 description 3
230000002194 synthesizing effect Effects 0.000 description 3
230000001225 therapeutic effect Effects 0.000 description 3
210000001519 tissue Anatomy 0.000 description 3
239000003643 water by type Substances 0.000 description 3
DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 2
YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 2
229940035437 1,3-propanediol Drugs 0.000 description 2
ZZHIDJWUJRKHGX-UHFFFAOYSA-N 1,4-bis(chloromethyl)benzene Chemical compound ClCC1=CC=C(CCl)C=C1 ZZHIDJWUJRKHGX-UHFFFAOYSA-N 0.000 description 2
ONBQEOIKXPHGMB-VBSBHUPXSA-N 1-[2-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)propan-1-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 ONBQEOIKXPHGMB-VBSBHUPXSA-N 0.000 description 2
238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 2
MWFLUYFYHANMCM-UHFFFAOYSA-N 2-(2-hydroxyethyl)isoindole-1,3-dione Chemical compound C1=CC=C2C(=O)N(CCO)C(=O)C2=C1 MWFLUYFYHANMCM-UHFFFAOYSA-N 0.000 description 2
OIMRLHCSLQUXLL-UHFFFAOYSA-N 3-chlorobutan-2-one Chemical compound CC(Cl)C(C)=O OIMRLHCSLQUXLL-UHFFFAOYSA-N 0.000 description 2
108020005075 5S Ribosomal RNA Proteins 0.000 description 2
BUNGCZLFHHXKBX-UHFFFAOYSA-N 8-methoxypsoralen Natural products C1=CC(=O)OC2=C1C=C1CCOC1=C2OC BUNGCZLFHHXKBX-UHFFFAOYSA-N 0.000 description 2
206010067484 Adverse reaction Diseases 0.000 description 2
OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 2
WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
OJRUSAPKCPIVBY-KQYNXXCUSA-N C1=NC2=C(N=C(N=C2N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(CP(=O)(O)O)O)O)O)I)N Chemical compound C1=NC2=C(N=C(N=C2N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(CP(=O)(O)O)O)O)O)I)N OJRUSAPKCPIVBY-KQYNXXCUSA-N 0.000 description 2
208000031404 Chromosome Aberrations Diseases 0.000 description 2
102100022133 Complement C3 Human genes 0.000 description 2
CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 2
102000004127 Cytokines Human genes 0.000 description 2
108090000695 Cytokines Proteins 0.000 description 2
239000003155 DNA primer Substances 0.000 description 2
IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 2
208000003870 Drug Overdose Diseases 0.000 description 2
PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 2
108010049003 Fibrinogen Proteins 0.000 description 2
102000008946 Fibrinogen Human genes 0.000 description 2
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
238000005727 Friedel-Crafts reaction Methods 0.000 description 2
241000282412 Homo Species 0.000 description 2
101001002508 Homo sapiens Immunoglobulin-binding protein 1 Proteins 0.000 description 2
OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
102100021042 Immunoglobulin-binding protein 1 Human genes 0.000 description 2
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
229930182816 L-glutamine Natural products 0.000 description 2
241000124008 Mammalia Species 0.000 description 2
239000012359 Methanesulfonyl chloride Substances 0.000 description 2
241000699670 Mus sp. Species 0.000 description 2
GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 2
101150101537 Olah gene Proteins 0.000 description 2
108091034117 Oligonucleotide Proteins 0.000 description 2
229930182555 Penicillin Natural products 0.000 description 2
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
239000004698 Polyethylene Substances 0.000 description 2
239000004721 Polyphenylene oxide Substances 0.000 description 2
239000004743 Polypropylene Substances 0.000 description 2
241000589516 Pseudomonas Species 0.000 description 2
CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 2
241000607142 Salmonella Species 0.000 description 2
BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
231100000643 Substance intoxication Toxicity 0.000 description 2
239000004098 Tetracycline Substances 0.000 description 2
PCWZKQSKUXXDDJ-UHFFFAOYSA-N Xanthotoxin Natural products COCc1c2OC(=O)C=Cc2cc3ccoc13 PCWZKQSKUXXDDJ-UHFFFAOYSA-N 0.000 description 2
230000002378 acidificating effect Effects 0.000 description 2
230000000274 adsorptive effect Effects 0.000 description 2
230000006838 adverse reaction Effects 0.000 description 2
238000013019 agitation Methods 0.000 description 2
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
229960000723 ampicillin Drugs 0.000 description 2
238000005349 anion exchange Methods 0.000 description 2
230000000840 anti-viral effect Effects 0.000 description 2
239000012736 aqueous medium Substances 0.000 description 2
235000019400 benzoyl peroxide Nutrition 0.000 description 2
239000013060 biological fluid Substances 0.000 description 2
239000012620 biological material Substances 0.000 description 2
238000009835 boiling Methods 0.000 description 2
229940098773 bovine serum albumin Drugs 0.000 description 2
230000031709 bromination Effects 0.000 description 2
238000005893 bromination reaction Methods 0.000 description 2
GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
229910052794 bromium Inorganic materials 0.000 description 2
JAMFGQBENKSWOF-UHFFFAOYSA-N bromo(methoxy)methane Chemical compound COCBr JAMFGQBENKSWOF-UHFFFAOYSA-N 0.000 description 2
239000007975 buffered saline Substances 0.000 description 2
VHRGRCVQAFMJIZ-UHFFFAOYSA-N cadaverine Chemical compound NCCCCCN VHRGRCVQAFMJIZ-UHFFFAOYSA-N 0.000 description 2
OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
231100000357 carcinogen Toxicity 0.000 description 2
231100000315 carcinogenic Toxicity 0.000 description 2
239000003183 carcinogenic agent Substances 0.000 description 2
239000000969 carrier Substances 0.000 description 2
238000004113 cell culture Methods 0.000 description 2
239000013553 cell monolayer Substances 0.000 description 2
239000006285 cell suspension Substances 0.000 description 2
230000001413 cellular effect Effects 0.000 description 2
229940061627 chloromethyl methyl ether Drugs 0.000 description 2
238000007265 chloromethylation reaction Methods 0.000 description 2
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
231100000005 chromosome aberration Toxicity 0.000 description 2
230000003541 clastogenic effect Effects 0.000 description 2
231100000010 clastogenicity Toxicity 0.000 description 2
230000015271 coagulation Effects 0.000 description 2
238000005345 coagulation Methods 0.000 description 2
239000011248 coating agent Substances 0.000 description 2
229960001338 colchicine Drugs 0.000 description 2
230000001332 colony forming effect Effects 0.000 description 2
229940125758 compound 15 Drugs 0.000 description 2
229940126142 compound 16 Drugs 0.000 description 2
238000010276 construction Methods 0.000 description 2
238000007334 copolymerization reaction Methods 0.000 description 2
150000004775 coumarins Chemical class 0.000 description 2
229960004397 cyclophosphamide Drugs 0.000 description 2
SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 2
SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 2
230000002939 deleterious effect Effects 0.000 description 2
238000011161 development Methods 0.000 description 2
229960004132 diethyl ether Drugs 0.000 description 2
239000006185 dispersion Substances 0.000 description 2
231100000725 drug overdose Toxicity 0.000 description 2
238000011067 equilibration Methods 0.000 description 2
XYIBRDXRRQCHLP-UHFFFAOYSA-N ethyl acetoacetate Chemical compound CCOC(=O)CC(C)=O XYIBRDXRRQCHLP-UHFFFAOYSA-N 0.000 description 2
229940093858 ethyl acetoacetate Drugs 0.000 description 2
238000000605 extraction Methods 0.000 description 2
229940012952 fibrinogen Drugs 0.000 description 2
239000000706 filtrate Substances 0.000 description 2
239000000834 fixative Substances 0.000 description 2
230000004907 flux Effects 0.000 description 2
239000011888 foil Substances 0.000 description 2
238000004817 gas chromatography Methods 0.000 description 2
231100000024 genotoxic Toxicity 0.000 description 2
239000001963 growth medium Substances 0.000 description 2
150000004820 halides Chemical group 0.000 description 2
239000000017 hydrogel Substances 0.000 description 2
239000005457 ice water Substances 0.000 description 2
239000012535 impurity Substances 0.000 description 2
230000002458 infectious effect Effects 0.000 description 2
239000003456 ion exchange resin Substances 0.000 description 2
229920003303 ion-exchange polymer Polymers 0.000 description 2
238000002955 isolation Methods 0.000 description 2
150000002605 large molecules Chemical class 0.000 description 2
231100000636 lethal dose Toxicity 0.000 description 2
239000007788 liquid Substances 0.000 description 2
238000004020 luminiscence type Methods 0.000 description 2
238000010338 mechanical breakdown Methods 0.000 description 2
108020004999 messenger RNA Proteins 0.000 description 2
QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 2
230000000813 microbial effect Effects 0.000 description 2
238000012544 monitoring process Methods 0.000 description 2
239000013642 negative control Substances 0.000 description 2
229910052757 nitrogen Inorganic materials 0.000 description 2
QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
230000003546 nucleic acid damage Effects 0.000 description 2
210000000056 organ Anatomy 0.000 description 2
150000002894 organic compounds Chemical class 0.000 description 2
230000003534 oscillatory effect Effects 0.000 description 2
238000004806 packaging method and process Methods 0.000 description 2
229940049954 penicillin Drugs 0.000 description 2
239000011301 petroleum pitch Substances 0.000 description 2
125000005544 phthalimido group Chemical group 0.000 description 2
238000002616 plasmapheresis Methods 0.000 description 2
238000007747 plating Methods 0.000 description 2
229920000768 polyamine Polymers 0.000 description 2
229920000570 polyether Polymers 0.000 description 2
229920000573 polyethylene Polymers 0.000 description 2
229920001155 polypropylene Polymers 0.000 description 2
229920000166 polytrimethylene carbonate Polymers 0.000 description 2
229920002981 polyvinylidene fluoride Polymers 0.000 description 2
238000004321 preservation Methods 0.000 description 2
XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 2
238000011946 reduction process Methods 0.000 description 2
238000006268 reductive amination reaction Methods 0.000 description 2
239000012508 resin bead Substances 0.000 description 2
229920006395 saturated elastomer Polymers 0.000 description 2
238000012216 screening Methods 0.000 description 2
229910052709 silver Inorganic materials 0.000 description 2
239000004332 silver Substances 0.000 description 2
239000012279 sodium borohydride Substances 0.000 description 2
229910000033 sodium borohydride Inorganic materials 0.000 description 2
229940063675 spermine Drugs 0.000 description 2
229960005322 streptomycin Drugs 0.000 description 2
KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical compound O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 2
238000001308 synthesis method Methods 0.000 description 2
239000006188 syrup Substances 0.000 description 2
235000020357 syrup Nutrition 0.000 description 2
229960002180 tetracycline Drugs 0.000 description 2
229930101283 tetracycline Natural products 0.000 description 2
235000019364 tetracycline Nutrition 0.000 description 2
150000003522 tetracyclines Chemical class 0.000 description 2
ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
238000011287 therapeutic dose Methods 0.000 description 2
231100000331 toxic Toxicity 0.000 description 2
231100000816 toxic dose Toxicity 0.000 description 2
230000002588 toxic effect Effects 0.000 description 2
XFNJVJPLKCPIBV-UHFFFAOYSA-N trimethylenediamine Chemical compound NCCCN XFNJVJPLKCPIBV-UHFFFAOYSA-N 0.000 description 2
239000001226 triphosphate Substances 0.000 description 2
230000035899 viability Effects 0.000 description 2
239000000080 wetting agent Substances 0.000 description 2
PGOHTUIFYSHAQG-LJSDBVFPSA-N (2S)-6-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-1-[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-methylsulfanylbutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-sulfanylpropanoyl]amino]-4-methylsulfanylbutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-oxopentanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-5-oxopentanoyl]amino]-3-phenylpropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-4-oxobutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-4-carboxybutanoyl]amino]-5-oxopentanoyl]amino]hexanoic acid Chemical compound CSCC[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(O)=O PGOHTUIFYSHAQG-LJSDBVFPSA-N 0.000 description 1
229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 description 1
WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
PHQFMPNZCIHSPC-UHFFFAOYSA-N 1,3,5-tris(chloromethyl)-2,4,6-trimethylbenzene Chemical group CC1=C(CCl)C(C)=C(CCl)C(C)=C1CCl PHQFMPNZCIHSPC-UHFFFAOYSA-N 0.000 description 1
INZDTEICWPZYJM-UHFFFAOYSA-N 1-(chloromethyl)-4-[4-(chloromethyl)phenyl]benzene Chemical group C1=CC(CCl)=CC=C1C1=CC=C(CCl)C=C1 INZDTEICWPZYJM-UHFFFAOYSA-N 0.000 description 1
IANQTJSKSUMEQM-UHFFFAOYSA-N 1-benzofuran Chemical compound C1=CC=C2OC=CC2=C1 IANQTJSKSUMEQM-UHFFFAOYSA-N 0.000 description 1
GXVUZYLYWKWJIM-UHFFFAOYSA-N 2-(2-aminoethoxy)ethanamine Chemical compound NCCOCCN GXVUZYLYWKWJIM-UHFFFAOYSA-N 0.000 description 1
OOAYUKLXGFBZJK-UHFFFAOYSA-N 3-(6-hydroxycyclopenta[c]pyran-1-yl)prop-2-enoic acid Chemical compound O1C=CC2=CC(O)=CC2=C1C=CC(=O)O OOAYUKLXGFBZJK-UHFFFAOYSA-N 0.000 description 1
WBIICVGYYRRURR-UHFFFAOYSA-N 3-(aminomethyl)-2,5,9-trimethylfuro[3,2-g]chromen-7-one Chemical compound O1C(=O)C=C(C)C2=C1C(C)=C1OC(C)=C(CN)C1=C2 WBIICVGYYRRURR-UHFFFAOYSA-N 0.000 description 1
KFKRXESVMDBTNQ-UHFFFAOYSA-N 3-[18-(2-carboxylatoethyl)-8,13-bis(1-hydroxyethyl)-3,7,12,17-tetramethyl-22,23-dihydroporphyrin-21,24-diium-2-yl]propanoate Chemical class N1C2=C(C)C(C(C)O)=C1C=C(N1)C(C)=C(C(O)C)C1=CC(C(C)=C1CCC(O)=O)=NC1=CC(C(CCC(O)=O)=C1C)=NC1=C2 KFKRXESVMDBTNQ-UHFFFAOYSA-N 0.000 description 1
ATVJXMYDOSMEPO-UHFFFAOYSA-N 3-prop-2-enoxyprop-1-ene Chemical compound C=CCOCC=C ATVJXMYDOSMEPO-UHFFFAOYSA-N 0.000 description 1
QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
MBVFRSJFKMJRHA-UHFFFAOYSA-N 4-fluoro-1-benzofuran-7-carbaldehyde Chemical compound FC1=CC=C(C=O)C2=C1C=CO2 MBVFRSJFKMJRHA-UHFFFAOYSA-N 0.000 description 1
FQWUNUXAOHTLLG-ASDGIDEWSA-N 6-[(3s,6s,9s,12r)-3,6-dibenzyl-2,5,8,11-tetraoxo-1,4,7,10-tetrazabicyclo[10.3.0]pentadecan-9-yl]-n-hydroxyhexanamide Chemical compound C([C@H]1C(=O)N2CCC[C@@H]2C(=O)N[C@H](C(N[C@@H](CC=2C=CC=CC=2)C(=O)N1)=O)CCCCCC(=O)NO)C1=CC=CC=C1 FQWUNUXAOHTLLG-ASDGIDEWSA-N 0.000 description 1
MVMMGVPSTRNMSV-UHFFFAOYSA-N 7-hydroxy-4,8-dimethylchromen-2-one Chemical compound CC1=C(O)C=CC2=C1OC(=O)C=C2C MVMMGVPSTRNMSV-UHFFFAOYSA-N 0.000 description 1
229940027041 8-mop Drugs 0.000 description 1
CFRFHWQYWJMEJN-UHFFFAOYSA-N 9h-fluoren-2-amine Chemical compound C1=CC=C2C3=CC=C(N)C=C3CC2=C1 CFRFHWQYWJMEJN-UHFFFAOYSA-N 0.000 description 1
RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
206010060935 Alloimmunisation Diseases 0.000 description 1
APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 description 1
241000272525 Anas platyrhynchos Species 0.000 description 1
101100313763 Arabidopsis thaliana TIM22-2 gene Proteins 0.000 description 1
239000004342 Benzoyl peroxide Substances 0.000 description 1
101800001577 C3a anaphylatoxin Proteins 0.000 description 1
241000283707 Capra Species 0.000 description 1
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
238000005821 Claisen rearrangement reaction Methods 0.000 description 1
229910020630 Co Ni Inorganic materials 0.000 description 1
102100022641 Coagulation factor IX Human genes 0.000 description 1
102100026735 Coagulation factor VIII Human genes 0.000 description 1
206010010075 Coma hepatic Diseases 0.000 description 1
229910002440 Co–Ni Inorganic materials 0.000 description 1
241000699802 Cricetulus griseus Species 0.000 description 1
NBSCHQHZLSJFNQ-GASJEMHNSA-N D-Glucose 6-phosphate Chemical compound OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O NBSCHQHZLSJFNQ-GASJEMHNSA-N 0.000 description 1
102000053602 DNA Human genes 0.000 description 1
108010076525 DNA Repair Enzymes Proteins 0.000 description 1
102000011724 DNA Repair Enzymes Human genes 0.000 description 1
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
239000006144 Dulbecco’s modiﬁed Eagle's medium Substances 0.000 description 1
108010067770 Endopeptidase K Proteins 0.000 description 1
108010076282 Factor IX Proteins 0.000 description 1
108010014172 Factor V Proteins 0.000 description 1
108010054218 Factor VIII Proteins 0.000 description 1
102000001690 Factor VIII Human genes 0.000 description 1
CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
229930182566 Gentamicin Natural products 0.000 description 1
VFRROHXSMXFLSN-UHFFFAOYSA-N Glc6P Natural products OP(=O)(O)OCC(O)C(O)C(O)C(O)C=O VFRROHXSMXFLSN-UHFFFAOYSA-N 0.000 description 1
208000031886 HIV Infections Diseases 0.000 description 1
229910004373 HOAc Inorganic materials 0.000 description 1
102000001554 Hemoglobins Human genes 0.000 description 1
108010054147 Hemoglobins Proteins 0.000 description 1
206010019663 Hepatic failure Diseases 0.000 description 1
241000700721 Hepatitis B virus Species 0.000 description 1
208000005176 Hepatitis C Diseases 0.000 description 1
229920000209 Hexadimethrine bromide Polymers 0.000 description 1
101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 description 1
101001125496 Homo sapiens Pre-mRNA-processing factor 19 Proteins 0.000 description 1
241000713340 Human immunodeficiency virus 2 Species 0.000 description 1
CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical class Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
241000239218 Limulus Species 0.000 description 1
239000006142 Luria-Bertani Agar Substances 0.000 description 1
102000012750 Membrane Glycoproteins Human genes 0.000 description 1
108010090054 Membrane Glycoproteins Proteins 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
LFZAGIJXANFPFN-UHFFFAOYSA-N N-[3-[4-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)piperidin-1-yl]-1-thiophen-2-ylpropyl]acetamide Chemical compound C(C)(C)C1=NN=C(N1C1CCN(CC1)CCC(C=1SC=CC=1)NC(C)=O)C LFZAGIJXANFPFN-UHFFFAOYSA-N 0.000 description 1
PHSPJQZRQAJPPF-UHFFFAOYSA-N N-alpha-Methylhistamine Chemical compound CNCCC1=CN=CN1 PHSPJQZRQAJPPF-UHFFFAOYSA-N 0.000 description 1
229910020889 NaBH3 Inorganic materials 0.000 description 1
206010028980 Neoplasm Diseases 0.000 description 1
206010067482 No adverse event Diseases 0.000 description 1
CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
206010033296 Overdoses Diseases 0.000 description 1
102000008212 P-Selectin Human genes 0.000 description 1
229910019213 POCl3 Inorganic materials 0.000 description 1
206010034567 Peripheral circulatory failure Diseases 0.000 description 1
241000206607 Porphyra umbilicalis Species 0.000 description 1
102100029522 Pre-mRNA-processing factor 19 Human genes 0.000 description 1
108010094028 Prothrombin Proteins 0.000 description 1
102100027378 Prothrombin Human genes 0.000 description 1
241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
108020004682 Single-Stranded DNA Proteins 0.000 description 1
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
108010006785 Taq Polymerase Proteins 0.000 description 1
206010043458 Thirst Diseases 0.000 description 1
108090000190 Thrombin Proteins 0.000 description 1
108010000499 Thromboplastin Proteins 0.000 description 1
102000002262 Thromboplastin Human genes 0.000 description 1
ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
208000003441 Transfusion reaction Diseases 0.000 description 1
DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 1
239000007983 Tris buffer Substances 0.000 description 1
208000027418 Wounds and injury Diseases 0.000 description 1
XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 1
150000001242 acetic acid derivatives Chemical class 0.000 description 1
DPKHZNPWBDQZCN-UHFFFAOYSA-N acridine orange free base Chemical compound C1=CC(N(C)C)=CC2=NC3=CC(N(C)C)=CC=C3C=C21 DPKHZNPWBDQZCN-UHFFFAOYSA-N 0.000 description 1
230000009471 action Effects 0.000 description 1
230000000996 additive effect Effects 0.000 description 1
239000002671 adjuvant Substances 0.000 description 1
239000002156 adsorbate Substances 0.000 description 1
150000001298 alcohols Chemical class 0.000 description 1
150000001299 aldehydes Chemical group 0.000 description 1
150000001335 aliphatic alkanes Chemical group 0.000 description 1
230000004075 alteration Effects 0.000 description 1
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
229910052782 aluminium Inorganic materials 0.000 description 1
125000004103 aminoalkyl group Chemical group 0.000 description 1
QXAITBQSYVNQDR-UHFFFAOYSA-N amitraz Chemical compound C=1C=C(C)C=C(C)C=1N=CN(C)C=NC1=CC=C(C)C=C1C QXAITBQSYVNQDR-UHFFFAOYSA-N 0.000 description 1
APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 1
229960003942 amphotericin b Drugs 0.000 description 1
150000001450 anions Chemical class 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
239000000427 antigen Substances 0.000 description 1
108091007433 antigens Proteins 0.000 description 1
102000036639 antigens Human genes 0.000 description 1
125000004429 atom Chemical group 0.000 description 1
239000003637 basic solution Substances 0.000 description 1
WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid group Chemical group C(C1=CC=CC=C1)(=O)O WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
DZBUGLKDJFMEHC-UHFFFAOYSA-N benzoquinolinylidene Natural products C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 1
NHOWLEZFTHYCTP-UHFFFAOYSA-N benzylhydrazine Chemical class NNCC1=CC=CC=C1 NHOWLEZFTHYCTP-UHFFFAOYSA-N 0.000 description 1
125000001743 benzylic group Chemical group 0.000 description 1
125000003180 beta-lactone group Chemical group 0.000 description 1
OTBHHUPVCYLGQO-UHFFFAOYSA-N bis(3-aminopropyl)amine Chemical compound NCCCNCCCN OTBHHUPVCYLGQO-UHFFFAOYSA-N 0.000 description 1
230000000740 bleeding effect Effects 0.000 description 1
238000009534 blood test Methods 0.000 description 1
238000007664 blowing Methods 0.000 description 1
239000005388 borosilicate glass Substances 0.000 description 1
XNNQFQFUQLJSQT-UHFFFAOYSA-N bromo(trichloro)methane Chemical compound ClC(Cl)(Cl)Br XNNQFQFUQLJSQT-UHFFFAOYSA-N 0.000 description 1
125000005997 bromomethyl group Chemical group 0.000 description 1
230000003139 buffering effect Effects 0.000 description 1
239000006227 byproduct Substances 0.000 description 1
201000011510 cancer Diseases 0.000 description 1
JJWKPURADFRFRB-UHFFFAOYSA-N carbonyl sulfide Chemical compound O=C=S JJWKPURADFRFRB-UHFFFAOYSA-N 0.000 description 1
239000003054 catalyst Substances 0.000 description 1
230000010261 cell growth Effects 0.000 description 1
210000003850 cellular structure Anatomy 0.000 description 1
229920003174 cellulose-based polymer Polymers 0.000 description 1
230000005465 channeling Effects 0.000 description 1
238000012512 characterization method Methods 0.000 description 1
239000007795 chemical reaction product Substances 0.000 description 1
239000007810 chemical reaction solvent Substances 0.000 description 1
239000003638 chemical reducing agent Substances 0.000 description 1
210000004978 chinese hamster ovary cell Anatomy 0.000 description 1
YTRQFSDWAXHJCC-UHFFFAOYSA-N chloroform;phenol Chemical compound ClC(Cl)Cl.OC1=CC=CC=C1 YTRQFSDWAXHJCC-UHFFFAOYSA-N 0.000 description 1
235000012000 cholesterol Nutrition 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
239000012539 chromatography resin Substances 0.000 description 1
210000000349 chromosome Anatomy 0.000 description 1
210000001726 chromosome structure Anatomy 0.000 description 1
150000001860 citric acid derivatives Chemical class 0.000 description 1
231100000505 clastogenic Toxicity 0.000 description 1
231100000313 clinical toxicology Toxicity 0.000 description 1
238000010367 cloning Methods 0.000 description 1
239000005321 cobalt glass Substances 0.000 description 1
238000004440 column chromatography Methods 0.000 description 1
229940125773 compound 10 Drugs 0.000 description 1
229940125898 compound 5 Drugs 0.000 description 1
ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
229910000366 copper(II) sulfate Inorganic materials 0.000 description 1
150000001907 coumarones Chemical class 0.000 description 1
239000013058 crude material Substances 0.000 description 1
238000005520 cutting process Methods 0.000 description 1
WZHCOOQXZCIUNC-UHFFFAOYSA-N cyclandelate Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C(O)C1=CC=CC=C1 WZHCOOQXZCIUNC-UHFFFAOYSA-N 0.000 description 1
230000002559 cytogenic effect Effects 0.000 description 1
HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 1
GYOZYWVXFNDGLU-XLPZGREQSA-N dTMP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)C1 GYOZYWVXFNDGLU-XLPZGREQSA-N 0.000 description 1
NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 1
230000002950 deficient Effects 0.000 description 1
239000008367 deionised water Substances 0.000 description 1
229910021641 deionized water Inorganic materials 0.000 description 1
239000005549 deoxyribonucleoside Substances 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
230000000779 depleting effect Effects 0.000 description 1
230000001627 detrimental effect Effects 0.000 description 1
150000004826 dibenzofurans Chemical class 0.000 description 1
235000014113 dietary fatty acids Nutrition 0.000 description 1
239000012470 diluted sample Substances 0.000 description 1
239000003085 diluting agent Substances 0.000 description 1
239000000539 dimer Substances 0.000 description 1
238000011037 discontinuous sequential dilution Methods 0.000 description 1
BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
229910000397 disodium phosphate Inorganic materials 0.000 description 1
238000006073 displacement reaction Methods 0.000 description 1
231100000673 dose–response relationship Toxicity 0.000 description 1
230000009977 dual effect Effects 0.000 description 1
239000000428 dust Substances 0.000 description 1
239000000975 dye Substances 0.000 description 1
230000000001 effect on platelet aggregation Effects 0.000 description 1
210000002969 egg yolk Anatomy 0.000 description 1
238000010894 electron beam technology Methods 0.000 description 1
238000001962 electrophoresis Methods 0.000 description 1
230000008030 elimination Effects 0.000 description 1
238000003379 elimination reaction Methods 0.000 description 1
239000003480 eluent Substances 0.000 description 1
238000000295 emission spectrum Methods 0.000 description 1
230000003511 endothelial effect Effects 0.000 description 1
229940088598 enzyme Drugs 0.000 description 1
CCIVGXIOQKPBKL-UHFFFAOYSA-N ethanesulfonic acid Chemical class CCS(O)(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-N 0.000 description 1
238000012869 ethanol precipitation Methods 0.000 description 1
ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
229960005542 ethidium bromide Drugs 0.000 description 1
IWBOPFCKHIJFMS-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl) ether Chemical compound NCCOCCOCCN IWBOPFCKHIJFMS-UHFFFAOYSA-N 0.000 description 1
230000005284 excitation Effects 0.000 description 1
230000007717 exclusion Effects 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
229960004222 factor ix Drugs 0.000 description 1
229960000301 factor viii Drugs 0.000 description 1
239000000194 fatty acid Substances 0.000 description 1
229930195729 fatty acid Natural products 0.000 description 1
150000004665 fatty acids Chemical class 0.000 description 1
230000002349 favourable effect Effects 0.000 description 1
239000012467 final product Substances 0.000 description 1
238000000684 flow cytometry Methods 0.000 description 1
MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
239000006260 foam Substances 0.000 description 1
125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
230000004927 fusion Effects 0.000 description 1
239000000499 gel Substances 0.000 description 1
229960002518 gentamicin Drugs 0.000 description 1
230000002070 germicidal effect Effects 0.000 description 1
238000011194 good manufacturing practice Methods 0.000 description 1
208000024908 graft versus host disease Diseases 0.000 description 1
239000008187 granular material Substances 0.000 description 1
230000009036 growth inhibition Effects 0.000 description 1
238000001631 haemodialysis Methods 0.000 description 1
125000005843 halogen group Chemical group 0.000 description 1
125000004970 halomethyl group Chemical group 0.000 description 1
238000003306 harvesting Methods 0.000 description 1
230000000322 hemodialysis Effects 0.000 description 1
201000001059 hepatic coma Diseases 0.000 description 1
208000007386 hepatic encephalopathy Diseases 0.000 description 1
208000006454 hepatitis Diseases 0.000 description 1
231100000283 hepatitis Toxicity 0.000 description 1
208000002672 hepatitis B Diseases 0.000 description 1
125000000623 heterocyclic group Chemical group 0.000 description 1
239000000833 heterodimer Substances 0.000 description 1
125000004836 hexamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 description 1
229960002885 histidine Drugs 0.000 description 1
235000014304 histidine Nutrition 0.000 description 1
239000000710 homodimer Substances 0.000 description 1
238000009396 hybridization Methods 0.000 description 1
230000007062 hydrolysis Effects 0.000 description 1
238000006460 hydrolysis reaction Methods 0.000 description 1
WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
239000013315 hypercross-linked polymer Substances 0.000 description 1
239000000815 hypotonic solution Substances 0.000 description 1
239000011261 inert gas Substances 0.000 description 1
239000012678 infectious agent Substances 0.000 description 1
230000036512 infertility Effects 0.000 description 1
239000003112 inhibitor Substances 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
230000000266 injurious effect Effects 0.000 description 1
208000014674 injury Diseases 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
239000000644 isotonic solution Substances 0.000 description 1
ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 1
230000002147 killing effect Effects 0.000 description 1
229920006008 lipopolysaccharide Polymers 0.000 description 1
208000007903 liver failure Diseases 0.000 description 1
231100000835 liver failure Toxicity 0.000 description 1
230000033001 locomotion Effects 0.000 description 1
210000004072 lung Anatomy 0.000 description 1
150000002688 maleic acid derivatives Chemical class 0.000 description 1
230000007257 malfunction Effects 0.000 description 1
210000004962 mammalian cell Anatomy 0.000 description 1
230000004060 metabolic process Effects 0.000 description 1
230000031864 metaphase Effects 0.000 description 1
229940098779 methanesulfonic acid Drugs 0.000 description 1
GEPDYQSQVLXLEU-AATRIKPKSA-N methyl (e)-3-dimethoxyphosphoryloxybut-2-enoate Chemical compound COC(=O)\C=C(/C)OP(=O)(OC)OC GEPDYQSQVLXLEU-AATRIKPKSA-N 0.000 description 1
MBABOKRGFJTBAE-UHFFFAOYSA-N methyl methanesulfonate Chemical compound COS(C)(=O)=O MBABOKRGFJTBAE-UHFFFAOYSA-N 0.000 description 1
YACKEPLHDIMKIO-UHFFFAOYSA-N methylphosphonic acid Chemical class CP(O)(O)=O YACKEPLHDIMKIO-UHFFFAOYSA-N 0.000 description 1
244000005700 microbiome Species 0.000 description 1
230000003278 mimic effect Effects 0.000 description 1
230000000877 morphologic effect Effects 0.000 description 1
231100000350 mutagenesis Toxicity 0.000 description 1
238000002703 mutagenesis Methods 0.000 description 1
231100000150 mutagenicity / genotoxicity testing Toxicity 0.000 description 1
JIKUXBYRTXDNIY-UHFFFAOYSA-N n-methyl-n-phenylformamide Chemical compound O=CN(C)C1=CC=CC=C1 JIKUXBYRTXDNIY-UHFFFAOYSA-N 0.000 description 1
229930014626 natural product Natural products 0.000 description 1
LGQLOGILCSXPEA-UHFFFAOYSA-L nickel sulfate Chemical compound [Ni+2].[O-]S([O-])(=O)=O LGQLOGILCSXPEA-UHFFFAOYSA-L 0.000 description 1
229910000363 nickel(II) sulfate Inorganic materials 0.000 description 1
150000002823 nitrates Chemical class 0.000 description 1
150000002829 nitrogen Chemical class 0.000 description 1
125000004433 nitrogen atom Chemical group N* 0.000 description 1
239000001272 nitrous oxide Substances 0.000 description 1
231100000252 nontoxic Toxicity 0.000 description 1
230000003000 nontoxic effect Effects 0.000 description 1
230000037435 normal mutation Effects 0.000 description 1
238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
239000012044 organic layer Substances 0.000 description 1
238000006053 organic reaction Methods 0.000 description 1
230000008520 organization Effects 0.000 description 1
229940021317 other blood product in atc Drugs 0.000 description 1
210000001672 ovary Anatomy 0.000 description 1
230000003647 oxidation Effects 0.000 description 1
238000007254 oxidation reaction Methods 0.000 description 1
239000006833 oxoid nutrient broth Substances 0.000 description 1
125000005429 oxyalkyl group Chemical group 0.000 description 1
238000001139 pH measurement Methods 0.000 description 1
IPCSVZSSVZVIGE-UHFFFAOYSA-N palmitic acid group Chemical group C(CCCCCCCCCCCCCCC)(=O)O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
239000008188 pellet Substances 0.000 description 1
230000010412 perfusion Effects 0.000 description 1
230000002572 peristaltic effect Effects 0.000 description 1
230000035699 permeability Effects 0.000 description 1
230000000144 pharmacologic effect Effects 0.000 description 1
UZRCGISJYYLJMA-UHFFFAOYSA-N phenol;styrene Chemical group OC1=CC=CC=C1.C=CC1=CC=CC=C1 UZRCGISJYYLJMA-UHFFFAOYSA-N 0.000 description 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
150000003904 phospholipids Chemical class 0.000 description 1
150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
230000000886 photobiology Effects 0.000 description 1
238000001782 photodegradation Methods 0.000 description 1
230000036470 plasma concentration Effects 0.000 description 1
108010058237 plasma protein fraction Proteins 0.000 description 1
229940081857 plasma protein fraction Drugs 0.000 description 1
230000010118 platelet activation Effects 0.000 description 1
231100000572 poisoning Toxicity 0.000 description 1
230000000607 poisoning effect Effects 0.000 description 1
229920002401 polyacrylamide Polymers 0.000 description 1
229920000447 polyanionic polymer Polymers 0.000 description 1
229920000515 polycarbonate Polymers 0.000 description 1
239000004417 polycarbonate Substances 0.000 description 1
229920000139 polyethylene terephthalate Polymers 0.000 description 1
239000005020 polyethylene terephthalate Substances 0.000 description 1
238000010094 polymer processing Methods 0.000 description 1
239000002952 polymeric resin Substances 0.000 description 1
229920000193 polymethacrylate Polymers 0.000 description 1
FYRHIOVKTDQVFC-UHFFFAOYSA-M potassium phthalimide Chemical compound [K+].C1=CC=C2C(=O)[N-]C(=O)C2=C1 FYRHIOVKTDQVFC-UHFFFAOYSA-M 0.000 description 1
239000002243 precursor Substances 0.000 description 1
238000011045 prefiltration Methods 0.000 description 1
150000003141 primary amines Chemical class 0.000 description 1
230000002250 progressing effect Effects 0.000 description 1
239000012460 protein solution Substances 0.000 description 1
229940039716 prothrombin Drugs 0.000 description 1
HUDHMIUZDXZZRC-UHFFFAOYSA-N protogonyautoxin 3 Chemical compound N=C1N(O)C(COC(=O)NS(O)(=O)=O)C2NC(=N)NC22C(O)(O)C(OS(O)(=O)=O)CN21 HUDHMIUZDXZZRC-UHFFFAOYSA-N 0.000 description 1
238000000746 purification Methods 0.000 description 1
239000005297 pyrex Substances 0.000 description 1
238000011002 quantification Methods 0.000 description 1
238000010791 quenching Methods 0.000 description 1
239000000376 reactant Substances 0.000 description 1
230000008707 rearrangement Effects 0.000 description 1
230000008439 repair process Effects 0.000 description 1
239000013557 residual solvent Substances 0.000 description 1
238000012552 review Methods 0.000 description 1
238000007363 ring formation reaction Methods 0.000 description 1
239000012266 salt solution Substances 0.000 description 1
239000004576 sand Substances 0.000 description 1
238000009738 saturating Methods 0.000 description 1
238000007423 screening assay Methods 0.000 description 1
229910052710 silicon Inorganic materials 0.000 description 1
239000010703 silicon Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
235000017557 sodium bicarbonate Nutrition 0.000 description 1
229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 1
AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
235000009518 sodium iodide Nutrition 0.000 description 1
235000019333 sodium laurylsulphate Nutrition 0.000 description 1
239000012064 sodium phosphate buffer Substances 0.000 description 1
OSQUFVVXNRMSHL-LTHRDKTGSA-M sodium;3-[(2z)-2-[(e)-4-(1,3-dibutyl-4,6-dioxo-2-sulfanylidene-1,3-diazinan-5-ylidene)but-2-enylidene]-1,3-benzoxazol-3-yl]propane-1-sulfonate Chemical compound [Na+].O=C1N(CCCC)C(=S)N(CCCC)C(=O)C1=C\C=C\C=C/1N(CCCS([O-])(=O)=O)C2=CC=CC=C2O\1 OSQUFVVXNRMSHL-LTHRDKTGSA-M 0.000 description 1
239000007790 solid phase Substances 0.000 description 1
239000012798 spherical particle Substances 0.000 description 1
239000010421 standard material Substances 0.000 description 1
230000000638 stimulation Effects 0.000 description 1
239000012609 strong anion exchange resin Substances 0.000 description 1
229960002317 succinimide Drugs 0.000 description 1
IIACRCGMVDHOTQ-UHFFFAOYSA-N sulfamic acid Chemical class NS(O)(=O)=O IIACRCGMVDHOTQ-UHFFFAOYSA-N 0.000 description 1
BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
229920003002 synthetic resin Polymers 0.000 description 1
150000003892 tartrate salts Chemical class 0.000 description 1
239000012085 test solution Substances 0.000 description 1
125000003698 tetramethyl group Chemical group [H]C([H])([H])* 0.000 description 1
229960000278 theophylline Drugs 0.000 description 1
238000005382 thermal cycling Methods 0.000 description 1
229960004072 thrombin Drugs 0.000 description 1
230000003582 thrombocytopenic effect Effects 0.000 description 1
230000036962 time dependent Effects 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
230000001988 toxicity Effects 0.000 description 1
231100000027 toxicology Toxicity 0.000 description 1
230000009466 transformation Effects 0.000 description 1
238000000844 transformation Methods 0.000 description 1
239000013638 trimer Substances 0.000 description 1
235000011178 triphosphate Nutrition 0.000 description 1
125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 1
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
101150060445 uvrB gene Proteins 0.000 description 1
230000002792 vascular Effects 0.000 description 1
210000003462 vein Anatomy 0.000 description 1
238000011179 visual inspection Methods 0.000 description 1
238000005406 washing Methods 0.000 description 1
239000008096 xylene Substances 0.000 description 1